Showing results (1021-1030 of 1,609) with videos related to

Sort By:
Pageof 161
JAMA Oncology|June 2, 2022
Treatment With Adjuvant Abemaciclib Plus Endocrine Therapy in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy: A Prespecified Analysis of the monarchE Randomized Clinical TrialMiguel Martin, Roberto Hegg, Sung-Bae Kim, et al.
JAMA Oncology|December 22, 2022
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional EvaluationLennard Y W Lee, Michael Tilby, Thomas Starkey, et al.
JAMA Oncology|December 8, 2022
Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant ChemotherapyToshitaka Sugawara, Salvador Rodriguez Franco, Samantha Sherman, et al.
JAMA Oncology|December 8, 2022
Association of Body Mass Index With the Safety Profile of Nivolumab With or Without IpilimumabJennifer L McQuade, Hans Hammers, Helena Furberg, et al.
JAMA Oncology|June 30, 2022
Effect of Apatinib Plus Pegylated Liposomal Doxorubicin vs Pegylated Liposomal Doxorubicin Alone on Platinum-Resistant Recurrent Ovarian Cancer: The APPROVE Randomized Clinical TrialTiantian Wang, Jie Tang, Hongying Yang, et al.
JAMA Oncology|September 24, 2020
Rationale for Immune Checkpoint Inhibitors Plus Targeted Therapy in Metastatic Melanoma: A ReviewReinhard Dummer, Paolo A Ascierto, Paul Nathan, et al.
JAMA Oncology|September 24, 2020
Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Adults With Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical TrialDouglas W Blayney, Qingyuan Zhang, Jifeng Feng, et al.
JAMA Oncology|April 3, 2020
Association Between Breastfeeding and Ovarian Cancer RiskAna Babic, Naoko Sasamoto, Bernard A Rosner, et al.
JAMA Oncology|October 8, 2020
Systemic Anti-PD-1 Immunotherapy Results in PD-1 Blockade on T Cells in the Cerebrospinal FluidJana Portnow, Dongrui Wang, M Suzette Blanchard, et al.
JAMA Oncology|October 29, 2020
Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma: A Randomized Clinical TrialTimothy F Cloughesy, Kevin Petrecca, Tobias Walbert, et al.
Pageof 161